Toremifene, a new agent for treatment of mastalgia: An open study

International Journal of Fertility and Women's Medicine

Volumn 49, Issue 6, 2004, Pages 278-280

  Hamed, H ^a   Kotheri, A ^a   Beechey Newman, N ^a   Fentiman, I S ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti estrogens; Chemotherapy; Tamoxifen

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TOREMIFENE;

ADULT; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; FEMALE; HUMAN; MIDDLE AGED; PAIN; TIME; TREATMENT OUTCOME;

ADULT; BREAST DISEASES; FEMALE; HUMANS; MIDDLE AGED; PAIN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TIME FACTORS; TOREMIFENE; TREATMENT OUTCOME;

EID: 14944350325     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mansel RE: The clinical assessment of mastalgia. Br J Clin Prac 43:(Supplement 68):17-20, 1989.
2. Cooper A: Illustrations of the diseases of the breast. Part I. Longman, Rees, Orme, Brown and Green. 1829.
3. England PC, Skinner LG, Cottrell KM, et al: Sex hormones in breast disease. Br J Surg 62:806-809, 1974.
4. Walsh PV, Bulbrook RD, Stell PM, et al: Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur J Clin Oncol 20:1339-1343, 1984. (Pubitemid 15202292)
5. Wang DY, Hayward JL, Bulbrook RD: Testosterone levels in the plasma of normal women and patients with benign breast disease or breast cancer. Eur J Cancer 2:373-376, 1966.
6. Cole EN, Sellwood RA, England PC, et al: Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Eur J Cancer 13:597-603, 1977. (Pubitemid 8126109)
7. Kumar S, Mansel RE, Hughes LE, et al: Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin Endocrinol 23:699-704, 1985. (Pubitemid 16186081)
8. Gateley GA, Bundred NJ, West RR, et al: Reproductive factors associated with mastalgia. Cancer Detect Prev 16:39-41, 1992.
9. Mansel RE, Dogliotti L: European multicentre trial of bromocriptine in cyclical mastalgia. Lancet i:190-193, 1990. (Pubitemid 20054579)
10. Mansel RE, Wisbey JR, Hughes LE: Controlled trial of the gonadotrophin danazol in painful nodular benign breast disease. Lancet i:928-931, 1982.
11. Fentiman IS, Caleffi M, Brame K, et al: Double blind controlled trial of tamoxifen therapy for mastalgia. Lancet ii:287-288, 1986. (Pubitemid 16134752)
12. Hamed H, Chaudary MA, Caleffi M, et al: LHRH analogue in the treatment of refractory and recurrent mastalgia. Ann R C S Eng 72:221-224, 1990. (Pubitemid 20307657)
13. DeFriend DJ, Howell A, Nicholson RI, et al: Investigations of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res 54: 408-414, 1994. (Pubitemid 24053178)
14. Maenpaa JU, Ala-Fossi S: Toremifene in postmenopausal breast cancer. Efficacy, safety and cost. Drug Therapy 11: 261-270, 1997. (Pubitemid 27464758)
15. Leinster SJ, Whitehouse GH, Walsh PV: Cyclical mastalgia: clinical and mammographic observations in screening population. Br J Surg 74:220-222, 1987. (Pubitemid 17044636)
16. Khan SA, Apkarian AV: Mastalgia and breast cancer: a protective association? Cancer Detect Prev 26:192-196, 2002.
17. Barros AC, Mottola J, Ruiz CA, et al: Reassurance in treatment of mastalgia. Breast J 5:162-165, 1999.
18. Ricciardi I, Lamniruberto A: Tamoxifen induced regression of benign breast lesions. Obstet Gynaecol 45:80-84, 1979. (Pubitemid 9166678)
19. Fentiman IS, Callefi M, Hamed H, et al: Dosage and duration of tamoxifen treatment in mastalgia: a controlled trial. Br J Surg 75:845-846, 1988.